You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dextenza

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Steroid Ophthalmic Insert Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Fluorometholone)

Not yet recruiting
  • Steroid Ophthalmic Insert
  • Dextenza 0.4Mg Ophthalmic Insert
  • Topical Fluorometholone
  • (no location specified)
Oct 17, 2022

Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)

Not yet recruiting
  • Vitreoretinopathy
  • +8 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • Pred Forte
  • Durham, North Carolina
    Duke Eye Center
Nov 10, 2022

Pterygium of Both Eyes Trial in Brandon (Intracanalicular Dexamethasone, (0.4 mg) Insert, Prednisolone Acetate)

Active, not recruiting
  • Pterygium of Both Eyes
  • Intracanalicular Dexamethasone, (0.4 mg) Insert
  • Prednisolone Acetate
  • Brandon, Florida
    Brandon Eye Associates
Jul 19, 2022

Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,

Not yet recruiting
  • Corneal Edema
  • +6 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • +3 more
  • Los Angeles, California
    Advanced Vision Care
Dec 5, 2022

Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate

Completed
  • Bilateral Conjunctivitis (Disorder)
  • Dexamethasone ophthalmic insert 0.4Mg
  • +2 more
  • Pompano Beach, Florida
    Clinical Research Center of Florida
Apr 6, 2022

Glaucoma, Cataract Trial in Bronx (Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)

Recruiting
  • Glaucoma
  • Cataract
  • Dexamethasone Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • Bronx, New York
    The New York Eye Surgery Center
Mar 20, 2022

Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)

Completed
  • Pterygium
  • Dexamethasone Intracanalicular Insert, 0.4mg
  • Prednisolone Acetate 1%
  • New York, New York
    New York Eye Specialists
Apr 4, 2022

Cataract Trial in Dayton (Dextenza 0.4Mg Ophthalmic Insert)

Completed
  • Cataract
  • Dextenza 0.4Mg Ophthalmic Insert
  • Dayton, Ohio
    Iworks Laser & Vision Center
Dec 22, 2022

Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular

Withdrawn
  • Graft Vs Host Disease
  • DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
  • Regular dissolvable intracanalicular plug
  • Boston, Massachusetts
    Mass Eye and Ear
Dec 14, 2021

Glaucoma Following Surgery Trial in Memphis (DEXTENZA, Topical Dexamethasone)

Not yet recruiting
  • Glaucoma Following Surgery
  • DEXTENZA
  • Topical Dexamethasone
  • Memphis, Tennessee
    Hamilton Eye Institute
Nov 9, 2021

Cataract Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Prednisolone)

Not yet recruiting
  • Cataract
  • Dextenza 0.4Mg Ophthalmic Insert
  • Topical Prednisolone
  • (no location specified)
Aug 25, 2021

Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,

Enrolling by invitation
  • Vitreoretinal Surgery
  • +3 more
  • Dexamethasone Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
Feb 24, 2022

Cataract Trial in Northbrook (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1%)

Enrolling by invitation
  • Cataract
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1%
  • Northbrook, Illinois
    Wyse Eyecare
Jan 17, 2023

Cataract Diabetic, Macula Edema Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)

Not yet recruiting
  • Cataract Diabetic
  • Macula Edema
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • (no location specified)
Jul 15, 2021

Dry Eye Trial in Baltimore (Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug)

Recruiting
  • Dry Eye
  • Sustained Release Dexamethasone, 0.4 mg
  • E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
  • Baltimore, Maryland
    Wilmer Eye Institute, Johns Hopkins School of Medicine
Jan 24, 2022

Post Procedural Infection Trial in Brecksville (Dexamethasone ophthalmic insert 0.4 mg)

Completed
  • Post Procedural Infection
  • Dexamethasone ophthalmic insert 0.4 mg
  • Brecksville, Ohio
    Cleveland Eye Clinic
Jul 26, 2021

Cataract Trial in United States (Dextenza, Prednisolone)

Recruiting
  • Cataract
  • Aurora, Colorado
  • +13 more
Jan 27, 2022

Dry Eye Trial in Hemet, Laguna Hills, Saint Louis (Dexamethasone)

Completed
  • Dry Eye
  • Hemet, California
  • +2 more
Dec 30, 2021

DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract

Completed
  • Anterior Chamber Inflammation
  • +7 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • Los Angeles, California
    Advanced Vision Care
Jul 14, 2021

Cataract Trial (Dexamethasone 0.4 MG [Dextenza])

Not yet recruiting
  • Cataract
  • Dexamethasone 0.4 MG [Dextenza]
  • (no location specified)
Nov 22, 2021

Ocular Rosacea Trial (Dextenza 0.4Mg Ophthalmic Insert, Fluoromethalone .01%)

Not yet recruiting
  • Ocular Rosacea
  • Dextenza 0.4Mg Ophthalmic Insert
  • Fluoromethalone .01%
  • (no location specified)
Apr 8, 2021

Dry Eye Syndromes Trial in Racine (Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears)

Completed
  • Dry Eye Syndromes
  • Dextenza 0.4Mg Intracanalicular Insert
  • Over the counter Artificial tears
  • Racine, Wisconsin
    The Eye Center of Racine
Apr 21, 2022

Ocular Disease Requiring Surgery Trial in Paso Robles, San Luis Obispo, Santa Maria (DEXTENZA®)

Not yet recruiting
  • Ocular Disease Requiring Surgery
  • Paso Robles, California
  • +2 more
Jan 28, 2021

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Saint Petersburg (Dextenza

Recruiting
  • Neovascular Age-related Macular Degeneration
  • +2 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate
  • Saint Petersburg, Florida
    Retina Vitreous Associates of Florida
Mar 10, 2021

Dry Eye Trial in Brecksville (Cyclosporin, Loteprednol Etabonate, Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert)

Completed
  • Dry Eye
  • Brecksville, Ohio
    Cleveland Eye Clinic
May 9, 2022